NeoGenomics Other Current Liab vs Other Current Assets Analysis

NEO Stock  USD 17.90  0.27  1.49%   
NeoGenomics financial indicator trend analysis is infinitely more than just investigating NeoGenomics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NeoGenomics is a good investment. Please check the relationship between NeoGenomics Other Current Liab and its Other Current Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeoGenomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in NeoGenomics Stock, please use our How to Invest in NeoGenomics guide.

Other Current Liab vs Other Current Assets

Other Current Liab vs Other Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NeoGenomics Other Current Liab account and Other Current Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between NeoGenomics' Other Current Liab and Other Current Assets is 0.91. Overlapping area represents the amount of variation of Other Current Liab that can explain the historical movement of Other Current Assets in the same time period over historical financial statements of NeoGenomics, assuming nothing else is changed. The correlation between historical values of NeoGenomics' Other Current Liab and Other Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Liab of NeoGenomics are associated (or correlated) with its Other Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Assets has no effect on the direction of Other Current Liab i.e., NeoGenomics' Other Current Liab and Other Current Assets go up and down completely randomly.

Correlation Coefficient

0.91
Relationship DirectionPositive 
Relationship StrengthVery Strong

Other Current Liab

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.
Most indicators from NeoGenomics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NeoGenomics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeoGenomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in NeoGenomics Stock, please use our How to Invest in NeoGenomics guide.At this time, NeoGenomics' Selling General Administrative is very stable compared to the past year. As of the 12th of December 2024, Sales General And Administrative To Revenue is likely to grow to 0.74, while Tax Provision is likely to drop (9.6 M).
 2021 2022 2023 2024 (projected)
Interest Expense5.1M1.5M6.9M7.3M
Depreciation And Amortization62.1M79.2M72.6M76.2M

NeoGenomics fundamental ratios Correlations

0.940.930.990.87-0.690.30.960.98-0.190.890.980.990.99-0.190.991.00.970.960.980.930.980.78-0.070.280.93
0.940.880.920.89-0.760.10.880.9-0.20.830.950.950.92-0.20.930.950.910.890.950.860.950.69-0.020.320.88
0.930.880.940.78-0.680.510.880.86-0.330.960.890.910.91-0.330.930.940.860.870.890.860.890.720.010.330.98
0.990.920.940.82-0.630.350.960.98-0.20.90.960.970.99-0.21.00.990.960.960.960.940.960.81-0.030.350.95
0.870.890.780.82-0.760.050.740.8-0.150.70.930.920.8-0.150.810.90.820.810.90.780.930.56-0.37-0.080.74
-0.69-0.76-0.68-0.63-0.76-0.03-0.67-0.610.17-0.62-0.75-0.75-0.630.17-0.63-0.71-0.65-0.7-0.77-0.45-0.77-0.390.250.09-0.67
0.30.10.510.350.05-0.030.270.22-0.320.540.180.220.29-0.320.320.30.210.290.180.30.190.260.080.20.53
0.960.880.880.960.74-0.670.270.98-0.160.850.940.940.98-0.160.970.940.970.970.960.880.940.770.070.370.9
0.980.90.860.980.8-0.610.220.98-0.150.830.960.960.99-0.150.980.960.990.970.970.920.960.79-0.030.350.87
-0.19-0.2-0.33-0.2-0.150.17-0.32-0.16-0.15-0.52-0.16-0.18-0.191.0-0.2-0.19-0.19-0.17-0.16-0.21-0.170.23-0.03-0.08-0.31
0.890.830.960.90.7-0.620.540.850.83-0.520.830.860.88-0.520.90.890.840.840.840.830.840.630.030.360.97
0.980.950.890.960.93-0.750.180.940.96-0.160.831.00.96-0.160.960.990.970.961.00.91.00.73-0.160.160.88
0.990.950.910.970.92-0.750.220.940.96-0.180.861.00.97-0.180.960.990.970.961.00.911.00.73-0.140.180.9
0.990.920.910.990.8-0.630.290.980.99-0.190.880.960.97-0.190.990.970.980.970.970.930.960.79-0.010.370.92
-0.19-0.2-0.33-0.2-0.150.17-0.32-0.16-0.151.0-0.52-0.16-0.18-0.19-0.2-0.19-0.19-0.17-0.16-0.21-0.170.23-0.03-0.08-0.31
0.990.930.931.00.81-0.630.320.970.98-0.20.90.960.960.99-0.20.980.970.950.960.930.960.81-0.010.40.94
1.00.950.940.990.9-0.710.30.940.96-0.190.890.990.990.97-0.190.980.960.950.980.930.990.77-0.110.220.93
0.970.910.860.960.82-0.650.210.970.99-0.190.840.970.970.98-0.190.970.960.980.970.920.970.70.00.30.87
0.960.890.870.960.81-0.70.290.970.97-0.170.840.960.960.97-0.170.950.950.980.960.860.960.7-0.070.290.88
0.980.950.890.960.9-0.770.180.960.97-0.160.841.01.00.97-0.160.960.980.970.960.891.00.74-0.130.190.89
0.930.860.860.940.78-0.450.30.880.92-0.210.830.90.910.93-0.210.930.930.920.860.890.890.730.110.280.86
0.980.950.890.960.93-0.770.190.940.96-0.170.841.01.00.96-0.170.960.990.970.961.00.890.72-0.150.160.88
0.780.690.720.810.56-0.390.260.770.790.230.630.730.730.790.230.810.770.70.70.740.730.72-0.020.410.75
-0.07-0.020.01-0.03-0.370.250.080.07-0.03-0.030.03-0.16-0.14-0.01-0.03-0.01-0.110.0-0.07-0.130.11-0.15-0.020.530.05
0.280.320.330.35-0.080.090.20.370.35-0.080.360.160.180.37-0.080.40.220.30.290.190.280.160.410.530.38
0.930.880.980.950.74-0.670.530.90.87-0.310.970.880.90.92-0.310.940.930.870.880.890.860.880.750.050.38
Click cells to compare fundamentals

NeoGenomics Account Relationship Matchups

NeoGenomics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets709.5M988.3M1.9B1.7B1.7B1.8B
Other Current Liab(1.6M)39.2M56.1M55.2M62.6M65.8M
Total Current Liabilities63.9M73.2M87.2M89.9M96.3M101.1M
Total Stockholder Equity507.4M694.3M1.1B998.0M941.5M988.6M
Net Debt(40.1M)(10.5M)296.0M347.7M269.2M282.7M
Retained Earnings(11.4M)(7.2M)(14.8M)(159.1M)(247.1M)(234.7M)
Accounts Payable50.1M25.0M17.9M20.5M20.3M11.8M
Cash173.0M228.7M316.8M263.2M342.5M359.6M
Cash And Short Term Investments173.0M296.3M515.4M438.0M415.2M436.0M
Common Stock Total Equity105K112K124K127K114.3K102.7K
Common Stock Shares Outstanding103.6M111.8M120.0M124.2M125.5M131.8M
Liabilities And Stockholders Equity709.5M988.3M1.9B1.7B1.7B1.8B
Non Current Liabilities Total138.2M220.9M674.3M652.1M643.4M675.6M
Total Liab202.1M294.0M761.5M742.0M739.7M776.7M
Total Current Assets290.7M448.7M681.5M605.3M596.8M626.7M
Common Stock105K112K124K127K114.3K102.7K
Property Plant And Equipment Net90.7M151.9M211.7M198.6M183.8M193.0M
Non Current Assets Total418.8M539.6M1.2B1.1B1.1B1.1B
Other Current Assets9.1M16.1M30.6M23.3M26.2M27.5M
Other Stockholder Equity520.3M701.4M1.1B1.2B1.2B1.2B
Property Plant And Equipment Gross90.7M131.7M321.6M330.5M342.0M359.1M
Accumulated Other Comprehensive Income(1.6M)10K(638K)(3.9M)(1.7M)(1.8M)
Property Plant Equipment64.2M85.9M211.7M102.5M117.9M123.8M
Short Long Term Debt Total132.9M218.2M612.8M610.9M611.7M642.3M
Current Deferred Revenue1.6M4.0M5.2M7.6M2.1M2.2M
Non Currrent Assets Other2.8M21.0M7.2M(29.7M)4.7M5.0M
Other Assets2.8M54.4M7.2M5.1M5.9M3.8M
Net Receivables94.2M106.8M112.1M119.7M131.2M137.8M
Inventory14.4M29.5M23.4M24.3M24.2M25.4M
Short Term Debt13.8M7.8M8.0M6.7M11.2M8.0M
Long Term Debt91.8M168.1M532.5M535.3M538.2M565.1M
Other Liab17.1M10.4M69.5M47.8M55.0M57.7M
Net Tangible Assets182.2M362.6M138.8M67.0M77.0M70.4M
Good Will198.6M211.1M527.1M522.8M601.2M631.2M
Retained Earnings Total Equity(11.4M)(7.2M)(14.8M)(159.1M)(143.2M)(136.0M)
Long Term Debt Total115.9M168.1M532.5M535.3M615.6M646.4M
Capital Surpluse520.3M701.4M1.1B1.2B1.3B1.4B
Capital Lease Obligations24.0M50.1M80.3M75.6M73.5M77.2M
Deferred Long Term Liab15.6M5.4M55.5M34.8M40.0M42.0M

Pair Trading with NeoGenomics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NeoGenomics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeoGenomics will appreciate offsetting losses from the drop in the long position's value.

Moving together with NeoGenomics Stock

  0.74DYAI Dyadic InternationalPairCorr

Moving against NeoGenomics Stock

  0.8HCM HUTCHMED DRCPairCorr
  0.6VALN Valneva SE ADRPairCorr
  0.56PFE Pfizer Inc Fiscal Year End 4th of February 2025 PairCorr
  0.54JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.46LLY Eli LillyPairCorr
The ability to find closely correlated positions to NeoGenomics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeoGenomics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeoGenomics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeoGenomics to buy it.
The correlation of NeoGenomics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeoGenomics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeoGenomics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NeoGenomics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether NeoGenomics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NeoGenomics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neogenomics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neogenomics Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeoGenomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in NeoGenomics Stock, please use our How to Invest in NeoGenomics guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeoGenomics. If investors know NeoGenomics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeoGenomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.306
Earnings Share
(0.61)
Revenue Per Share
5.098
Quarterly Revenue Growth
0.104
Return On Assets
(0.03)
The market value of NeoGenomics is measured differently than its book value, which is the value of NeoGenomics that is recorded on the company's balance sheet. Investors also form their own opinion of NeoGenomics' value that differs from its market value or its book value, called intrinsic value, which is NeoGenomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeoGenomics' market value can be influenced by many factors that don't directly affect NeoGenomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeoGenomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if NeoGenomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeoGenomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.